News & Updates

Show Multimedia Only

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024 by

Dual triggering with gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) was not superior to GnRHa alone in terms of mature oocyte retrieval for elective fertility preservation, according to a study presented at ESHRE 2024.

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024

Galcanezumab a safer choice than prednisone for medication overuse headache

26 Jul 2024 by

Both galcanezumab and prednisone effectively relieve pain in people with medication overuse headache (MOH), with combination therapy using both medications yielding the greatest benefit, according to the results of a three-arm, head-to-head observational study. However, the use of prednisone is accompanied by an increased frequency of adverse events.

Galcanezumab a safer choice than prednisone for medication overuse headache

26 Jul 2024

Real-world data favour tirzepatide over semaglutide for weight loss

25 Jul 2024 by

Tirzepatide appears to yield substantially greater reductions in weight than semaglutide in the real-world treatment of overweight or obesity in adults with or without diabetes, according to a study.

Real-world data favour tirzepatide over semaglutide for weight loss

25 Jul 2024

Is it safe for coeliac disease patients to take antiobesity drugs?

25 Jul 2024

Patients with coeliac disease (CD) on a gluten-free diet and are treated with anti obesity medications (AOMs) show comparable weight loss outcomes to those without CD, reports a study.

Is it safe for coeliac disease patients to take antiobesity drugs?

25 Jul 2024

Do antidepressants induce mania in patients with bipolar depression?

25 Jul 2024

Use of antidepressants does not contribute to the risk of mania, as shown in a study. There is also no association observed between antidepressants and recurrence of bipolar depression.

Do antidepressants induce mania in patients with bipolar depression?

25 Jul 2024

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024 by

In the phase II OXOART2 trial presented at ESHRE 2024, the first-in-class, non-hormonal, oral agent OXO-001 increases implantation and pregnancy rates in infertile women ≤40 years undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

25 Jul 2024

Response-adapted radiation therapy (RT) shows promise in the treatment of indolent orbital B-cell lymphoma, conferring high local control rates while reducing radiation exposure, according to the results of a phase II nonrandomized controlled trial.

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

25 Jul 2024

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

24 Jul 2024

The IL-13 inhibitor cendakimab appears to be beneficial in the treatment of atopic dermatitis (AD), with the results of a phase II study showing that a dosing schedule of 720 mg once weekly helps reduce the severity of the said condition.

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

24 Jul 2024

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024 by

Argatroban appears to reduce neurological deficits in acute ischaemic stroke (AIS) patients with early neurological deterioration (END) who are undergoing thrombolytic therapy, without increasing the risk of symptomatic intracranial haemorrhage, according to the results of a meta-analysis.

Meta-analysis strengthens case for argatroban use in patients with END after stroke

24 Jul 2024

Endometrial cancer in women under 40 years of age

24 Jul 2024 by

Endometrial cancer affects the lining of the uterus (ie, the endometrium). In Singapore, endometrial cancer is the most common gynaecological cancer, with an increasing incidence over the past few decades, corresponding to global trends associated with factors such as changing lifestyles, obesity, and hormonal influences.

Endometrial cancer in women under 40 years of age

24 Jul 2024

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Galcanezumab a safer choice than prednisone for medication overuse headache

Galcanezumab a safer choice than prednisone for medication overuse headache

Real-world data favour tirzepatide over semaglutide for weight loss

Real-world data favour tirzepatide over semaglutide for weight loss

Is it safe for coeliac disease patients to take antiobesity drugs?

Is it safe for coeliac disease patients to take antiobesity drugs?

Do antidepressants induce mania in patients with bipolar depression?

Do antidepressants induce mania in patients with bipolar depression?

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

Response-adapted ultralow-dose RT may improve indolent orbital B-cell lymphoma outcomes

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

Investigational IL-13 inhibitor shows therapeutic potential in atopic dermatitis

Meta-analysis strengthens case for argatroban use in patients with END after stroke

Meta-analysis strengthens case for argatroban use in patients with END after stroke

Endometrial cancer in women under 40 years of age

Endometrial cancer in women under 40 years of age